GöteborgBIO http://www.goteborgbio.se/communicationroom/rss/rss10latestnews.4.4e71cfb112f54fdc91b80001118.html 10 Latest news en GöteborgBIO SiteVision 2.6.2 Fri, 21 Dec 2012 18:18:12 +0100 New implant replaces damaged middle ear Hearing damage is the most common physical handicap in the industrialised world. People who are functionally deaf can now achieve normal hearing thanks to a new implant that replaces the middle ear. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/newimplantreplacesdamagedmiddleear.5.5f36b02b13b95513717daa.html Thu, 20 Dec 2012 17:25:00 +0100 Professor Jens Nielsen awarded by Nature Professor Jens Nielsen recieves the 2012 Nature Award for Mentoring in Science (Nordic countries) for his outstanding efforts to mentor young researchers. "Jens Nielsen is an extremely supportive, innovative and solution oriented mentor," says Hans Wigzell, chair of judges for the 2012 Awards. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/professorjensnielsenawardedbynature.5.5f36b02b13b95513717d8e.html Tue, 11 Dec 2012 13:23:40 +0100 Medfield Diagnostics: New MD takes office in January Dag Jungenfelt has been appointed as new Managing Director of Medfield Diagnostics from the 1st of January 2013. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/medfielddiagnosticsnewmdtakesofficeinjanuary.5.249e750913abda23d1c3773.html Tue, 11 Dec 2012 10:34:23 +0100 Region Västra Götaland Delegation Visit to India Region Västra Götaland represented by Sahlgrenska International Care, Sahlgrenska University Hospital, Gothia Forum, Business Region Göteborg and the Unit for International Coordination is on a delegation visit to India focusing on collaboration within life science. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/regionvastragotalanddelegationvisittoindia.5.249e750913abda23d1c36e2.html Mon, 10 Dec 2012 16:16:26 +0100 108 business-to-business meetings between Swedish and French life science players at oncology seminar in Paris The three major Swedish life science regions (Gothenburg, Skåne and Stockholm) and the Paris Life Science cluster Medicen jointly organised a successful scientific business meeting in the heart of the French capital on December 5, 2012. The objective was to identify R&D collaboration opportunities between Swedish and French innovative companies and organisations in the field of cancer research. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/108businesstobusinessmeetingsbetweenswedishandfrenchlifescienceplayersatoncologyseminarinparis.5.249e750913abda23d1c3562.html Wed, 28 Nov 2012 11:09:27 +0100 Swedish Life Science stars to Paris - hunting for prominent French oncology partners On 5 December 2012, representatives from 12 of Sweden's most innovative Life Science companies will travel to Paris looking for French partners within oncology. A number of these are from west Sweden. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/swedishlifesciencestarstoparishuntingforprominentfrenchoncologypartners.5.249e750913abda23d1c2845.html Wed, 28 Nov 2012 10:06:44 +0100 Duocort leader Maria Forss awarded Maria Forss is Project Manager of the Year 2012. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/duocortleadermariaforssawarded.5.249e750913abda23d1c2829.html Tue, 27 Nov 2012 09:33:48 +0100 The world's first mind-controlled implantable robotic arm The world´s first implantable robotic arm controlled by thoughts is developed by researcher Max Ortiz Catalan, at the Department of Signals and Systems, Chalmers University of Technology in collboration with Integrum AB and Sahlgrenska University Hospital. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/theworldsfirstmindcontrolledimplantableroboticarm.5.249e750913abda23d1c275c.html Fri, 23 Nov 2012 14:28:03 +0100 Growth is on the agenda for ViroPharma Sweden When ViroPharma Inc. invested in a Swedish medical innovation in 2011, the US company decided to locate its Nordic regional office at Sahlgrenska Science Park in Gothenburg. Since its establishment in June, ViroPharma Sweden AB has expanded rapidly and further recruitments to add to the company's existing six employees are anticipated. Growth is on the agenda, as is the work to develop a local network of collaboration partners, according to Roger Johansson, CEO of ViroPharma Sweden. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/growthisontheagendaforviropharmasweden.5.249e750913abda23d1c206c.html Tue, 20 Nov 2012 12:03:34 +0100 Sverige som ett internationellt centrum för Life Science Västsverige deltar i arbetet att skapa en gemensam nationell agenda inom Life Science-området. http://www.goteborgbio.se/nyhetsarkiv/nyhetsarkiv2012/sverigesomettinternationelltcentrumforlifescience.5.249e750913abda23d1c1d94.html